Interaction of antimicrobial peptides with bacterial polysaccharides from lung pathogens
- 26 February 2005
- Vol. 26 (7) , 1127-1132
- https://doi.org/10.1016/j.peptides.2005.01.020
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Microbiological characterisation ofBurkholderia cepaciaisolates from cystic fibrosis patients: investigation of the exopolysaccharides producedFEMS Microbiology Letters, 2002
- Structural Study of the Exopolysaccharide Produced by a Clinical Isolate of Burkholderia cepaciaBiochemical and Biophysical Research Communications, 2000
- Structural features and biological activities of the cathelicidin-derived antimicrobial peptidesBiopolymers, 2000
- Bacterial Biofilms: A Common Cause of Persistent InfectionsScience, 1999
- The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surfaceProceedings of the National Academy of Sciences, 1998
- Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37Journal of Biological Chemistry, 1998
- Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.Microbiological Reviews, 1996
- FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis.Proceedings of the National Academy of Sciences, 1995
- Structural determnation of the capsular polysaccharide produced by Klebsiella pneumoniae serotype K40European Journal of Biochemistry, 1993
- Type-specific carbohydrate antigens of pathogenic bacteria. Part 1: EnterobacteriaceaeCarbohydrate Polymers, 1991